WICHITA FALLS, Texas--(BUSINESS WIRE)--As the year draws to an end the Federal Communications Commission is making consumers aware of the looming 3G shutdown as described in this article Plan Ahead ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

Cardiogen is a short regulatory peptide that has attracted sustained scientific curiosity within molecular biology and tissue signaling research. Classified among low–molecular–weight peptide ...

He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

(Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a company update. Company Highlights The IMG-007 ...

Coherus Oncology (NASDAQ:CHRS) executives said the company has moved quickly through a multi-year transformation toward ...

Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and biomarker discovery in proteomics.

Cellular neuroscience is the study of neurons at the cellular level. It includes cell morphology and physiological properties such as membrane trafficking, synthesis and transport of proteins, and ...